Clinical trial
Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of…
NCT00027144 · University of Connecticut, Other · Completed
Key facts
| NCT number | NCT00027144 |
|---|---|
| Title | Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase |
| Official title | A Feasibility and Toxicity Study of Vaccination With HSP70 for the Treatment of Chronic Myelogenous Leukemia in the Chronic Phase |
| Lead sponsor | University of Connecticut, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia, Myeloid, Chronic, Philadelphia-Positive |
| Intervention type | Biological |
| Interventions | Heat Shock Protein 70 HSP70 |
| Enrollment | 10 |
| Start date | Dec 1, 2000 |
| Completion | Oct 1, 2002 |
| First posted | Nov 28, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: